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Abstract
DNA cytosine methylation (5-methylcytosines) represents a key epigenetic mark and is required 
for normal development. Iterative oxidation of 5mC by TET family of DNA dioxygenases 
generates three oxidized nucleotides, 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), 
and 5-carboxycytosine (5caC), in the mammalian genome. Recent advances in genomic mapping 
techniques for these oxidized bases suggest that 5hmC/5fC/5caC are not only functionally relevant 
to the process of active reversal of 5mC, but may also possess unique regulatory functions. This 
perspective highlights the potential gene regulatory functions of these oxidized cytosine bases in 
the mammalian genome, and discusses the principles and limitations of recently developed base-
resolution mapping technologies.
Introduction
Methylation of DNA allows the genome to carry regulatory information beyond its 
canonical function as genetic blueprint. In bacteria, methylation can occur on either 
adenosine or cytosine, impacting diverse biological processes such as degrading foreign 
DNA, tracking mismatch repair and regulating DNA replication 1. DNA methylation at the 
5-position of cytosine (5mC) is evolutionarily conserved in many eukaryotic organisms and 
has been functionally linked to gene expression regulation and genome integrity 
maintenance 2. Intriguingly, recent studies indicate that adenosine methylation such as N6-
methyladenision (6mA), is present in eukaryotic organisms (C. elegans and D. 
melanogaster) that are previously thought to lack DNA methylation 3,4, raising the 
possibility that DNA methylation has a general role in eukaryotic biology.
In vertebrates, cytosine methylation (5mC) is the predominant form of DNA modification 
and occurs throughout the entire genome, suggesting that their methylation might be a 
default state 5,6. De novo DNA methyltransferases (DNMT3A and DNMT3B) primarily 
target 5mC to palindromic CpG dinucleotide and the maintenance DNA methyltransferase 
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(DNMT1) enables faithful propagation of CpG methylation patterns through cell divisions 7. 
Heritable CpG methylation (mCpG) is therefore considered as a classic ‘epigenetic’ mark 
and is believed to be functionally involved in many forms of long-term epigenetic memory 
processes, such as genomic imprinting, X chromosome inactivation and silencing of 
repeats 8. Interestingly, highly dynamic changes of DNA methylation take place at a 
genome-wide scale during early embryonic development and is required for critical 
biological processes such as erasure of parental-origin-specific imprints in developing 
primordial germ cells (PGCs) 9,10. In addition, genome-wide mapping of 5mC revealed that 
active gene regulatory sequences, such as gene promoters and distal enhancers, are 
hypomethylated 11,12. Because these DNA demethylation processes are not always coupled 
with DNA replication-dependent passive dilution of 5mC, specific enzymatic activity may 
exist for active removal of 5mC in vertebrates. Recent discovery of the ten-eleven 
translocation (TET) family of 5mC dioxygenases has provided a biochemically plausible 
pathway for catalyzing active DNA demethylation process 13,14. TET proteins convert 5mC 
into 5-hydroxymethylcytosine (5hmC) 15–17. Further successive oxidations mediated by 
TET result in 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) 18,19, both of which 
can be efficiently excised by Thymine DNA glycosylase (TDG) and restored to unmodified 
cytosines through base excision repair (BER) pathway 18,20,21. Genetic studies of TET 
mutant mice indicated that these 5mC oxidases play important roles in diverse biological 
processes, including embryonic development, stem cell differentiation, erasure of genomic 
imprinting, learning and memory, and cancer [reviewed in 13,14].
In addition to function as intermediates of an active DNA demethylation pathway (Fig. 1a), 
growing evidence indicates that these oxidized methylcytosines may possess unique 
regulatory functions. To gain insight into the potential function of 5hmC, 5fC, and 5caC, 
several studies have attempted to identify reader proteins for oxidized methylcytosines 22,23 
(Fig. 1b). These studies not only identified proteins that are functionally linked to DNA 
repair process, but also uncovered transcription factors and chromatin modifying enzymes as 
candidate reader proteins for oxidized 5mC bases. Interestingly, the number of identified 
candidates for 5fC and 5caC is much higher than that of 5hmC, possibly due to the unique 
chemical properties of formyl and carboxyl groups of these two highly oxidized bases. In 
addition, biochemical and structural evidences indicate that 5fC and 5caC within the gene 
body may reduce the elongation rate of RNA polymerase II (Pol II) 24,25 (Fig. 1c). 
Furthermore, biophysical studies suggest that these oxidized bases may have impact on 
base-pairing and DNA structure 26,27, suggesting that these chemical modifications may 
affect DNA-templated processes by directly impact DNA conformation. Lastly, potential 
single or double strand breaks associated with the DNA repair process downstream of 5fC/
5caC excision may contribute to gene regulation 13.
Understanding the mechanisms underlying these roles require the ability to comprehensively 
profile the distribution of the reactions that TET and TDG enzymes catalyze in the 
mammalian genome. Recent technological advances have results in genomic maps of 
oxidized 5mC bases (5hmC/5fC/5caC) at unprecedented resolution, revealing that TET-
mediated 5mC oxidation events are preferentially targeted to genomic regions associated 
with gene regulatory functions. Despite these intriguing but correlative observations, exactly 
how oxidized 5mC bases exert their function at these regulatory regions is largely unclear 
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and is under active investigation 28. This perspective summarizes recent advances in 
genomic mapping methods for oxidized 5mC bases (5hmC/5fC/5caC), and discuss the 
potential functions of 5mC and its oxidized derivatives as stable and transient epigenetic 
marks in gene regulation.
Genomic mapping of oxidized 5-methylcytosines at single-base resolution
As the first enzymatic product of TET-mediated 5mC oxidation, 5hmC is detected in a broad 
spectrum of mammalian tissues. In contrast to the relatively high 5mC levels, which are 
stable across somatic tissues (~4% of total cytosines), the levels of 5hmC are highly variable 
in a tissue specific manner. For instance, 5hmC can be as high as 40% of the 5mC level in 
Purkinje neurons in cerebellum 15, ~5% of the 5mC level in embryonic stem cells 
(ESCs) 16,17, and as low as ~1% of 5mC in some immune cells 29. While 5hmC is generally 
considered as an intermediate of TET-mediated active DNA demethylation, recent studies 
have suggested that the majority of 5hmC is a stable modification in mouse tissues 30. 
Iterative oxidation of 5hmC by TET generates 5fC and 5caC, which are present ~100-fold 
lower than the level of 5hmC in wild-type ESCs 19. The low abundance of 5fC [~20 Parts 
Per Million (ppm) cytosines in ESCs] and 5caC (~3 ppm) is in part due to the robust 5fC/
5caC excision activity of TDG in mammalian cells. Indeed, depletion of TDG in mouse 
ESCs results in 5–10 fold increase in the levels of 5fC and 5caC 31,32, suggesting that the 
majority of 5fC and 5caC are only transiently present in the mammalian genome. One 
potential exception to the transitory presence of 5fC and 5caC is the initial generation and 
eventual replication-dependent dilution of 5fC and 5caC in early pre-implantation 
embryos 33, where TDG mRNAs are not detected. Using a stable isotope tracing strategy, a 
recent study indicates that 5fC can be a stable DNA modification in nonproliferating cells or 
postnatal tissues 34, albeit at low levels (ranging from 0.2 to 15 ppm in different tissues). 
The total amount of oxidized cytosine bases can be quantified by several methods, including 
thin layer chromatography, modification-specific antibodies, chemical tagging, and mass 
spectrometry [reviewed in 35].
Genome-wide mapping of oxidized 5mC variants in mammalian genomes is technically 
challenging due to their extremely low abundances. Early efforts in mapping these modified 
nucleotides relied predominantly on affinity-enrichment based methods that utilize either 
modification-specific antibodies or chemical tagging 36,37. However, genomic maps of 
5hmC/5fC/5caC generated by these affinity-enrichment methods are of limited resolution 
(several hundred base-pairs), represent only relative enrichment (over control experiments) 
and lack precise strand distribution information. To address these limitations, methods have 
been developed recently to discriminate the different 5mC oxidation variants at single-base 
resolution at genome-scale (Fig. 2). Importantly, results from these studies have provided 
new insights into the biological functions of these oxidized cytosine bases in the mammalian 
genome.
Base-resolution mapping of 5hmC in mammalian genomes
The current method of choice for mapping cytosine methylation at single-base resolution is 
sodium bisulfite (NaHSO3) conversion of genomic DNA followed by next-generation 
sequencing (BS-seq). In BS-seq, 5mC and 5hmC are resistant to deamination and 
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consequently be read out as cytosine (C) after PCR amplification; unmodified C, 5fC and 
5caC are deaminated in bisulfite treatment and read out as thymine (T) in subsequent 
sequencing. Thus, methylation signals (C) in standard BS-seq represent the sum of 5mC and 
5hmC. To map 5hmC at base-resolution, several modified bisulfite-sequencing method have 
been developed (Fig. 2).
The first method, termed oxidative bisulfite sequencing (oxBS-seq), utilizes potassium 
perruthenate (KRuO4) to specifically oxidize 5hmC to 5fC. Thus, 5hmC (now converted to 
5fC) is detected as T, whereas only 5mC remains intact and is read out as C. While 5mC is 
directly mapped, subtracting signals of oxBS-seq maps (5mC) from those of traditional BS-
seq (5mC+5hmC) would reveal the absolute level and precise location of 5hmC 38. Because 
this method requires subtraction between two random sampling-based BS-seq experiments, 
it requires very deep sequencing coverage to achieve relatively high-confidence mapping of 
5hmC. One strategy to reducing sequencing effort is to combine reduced representation BS-
seq (RRBS) strategy with oxBS-seq 38. In this oxRRBS approach, converted DNA was first 
digested with the MspI enzyme (C^CGG, “^” is the cutting site) to enrich for CpG-
containing DNA fragments. It thus allows deep (~120× per cytosine) and selective 
sequencing of a fraction of the genome that is highly enriched for CpG-rich sequences such 
as CpG islands (CGIs) and certain-types of repeats. Application of the oxRRBS to mouse 
ESCs have revealed that 5hmC is relatively enriched at transcriptionally poised and CpG-
rich promoters that drive expression of lineage-specific transcription factors during cellular 
differentiation. In fact, 5hmC enrichment at promoter is negatively correlated with the 
steady state level of transcription. These results are consistent with results from 5hmC maps 
generated by affinity enrichment-based methods 39,40.
The second base-resolution 5hmC mapping method is called Tet-assisted bisulfite 
sequencing (TAB-seq), which involves TET-mediated enzymatic conversion of non-5hmC 
modifications (5mC/5fC) to 5caC followed by bisulfite sequencing 41. In TAB-seq, 5hmC is 
first protected from TET-mediated oxidation by glucosylation using β-glucosyltransferase 
(β-GT). 5mC and 5fC are then oxidized to 5caC in the presence of high concentration of 
recombinant TET1 proteins. Thus, C/5mC/5fC/5caC are detected as T, whereas only 
glucosylated 5hmC is read as C. A major advantage of TAB-seq is that 5hmC is directly 
mapped, which reduces the sequencing effort needed for high confidence 5hmC mapping 41. 
As a result, application of TAB-seq to human and mouse ESCs enabled the generation of 
first whole-genome maps of 5hmC at base-resolution. With a medium sequencing depth 
(17–26× per cytosine) and stringent statistical filtering, TAB-seq can identify the precise 
position and quantify the absolute abundance of 5hmC of 20% or higher. A total of ~0.7 and 
~2.1 million high-confidence 5hmC sites have been identified in human and mouse ESCs, 
respectively (Table 1). Whole-genome map of 5hmC revealed that 5hmC is highly enriched 
at many CpG-poor and promoter-distal gene regulatory regions such as p300-marked 
enhancers and CTCF-bound insulators, which are generally under-represented in RRBS 
datasets. Previous affinity enrichment-based maps also suggested that 5hmC is enriched at 
distal cis-regulatory elements 39,42,43, but lacked the resolution required for investigating the 
relationship between 5hmC position and transcription factor (TF) binding motifs. The base-
resolution map revealed that 5hmC is typically not detected within TF binding sites but 
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rather is most enriched in regions immediately adjacent to TF motifs, generating bimodal 
peaks of 5hmC centered at the motif. Mammalian nervous systems possess the highest level 
of 5hmC among all somatic tissues. Age-dependent increase of total 5hmC levels in cortex, 
hippocampus and cerebellum supports a role of 5hmC as a stable epigenetic mark in 
neuronal genomes 44. Indeed, whole-genome TAB-seq analysis of fetal and young adult 
frontal cortex not only confirmed a general increase of 5hmC at various genomic features in 
adult brain compared to fetal brains, but also revealed an overall positive correlation 
between intragenic 5hmC enrichment (in CpG context) and transcriptional activity 45. In 
addition to ESCs and brains, TAB-seq has also been used to analyze the 5hmC pattern in 
two-cell embryos 46. Combined with paternal/maternal allele specific analysis, TAB-seq 
(18× per cytosine) has identified ~0.1 million 5hmCpGs in paternal genome and ~0.12 
million 5hmCpGs in maternal genome, suggesting that TET-mediated 5mC oxidation takes 
place on both sperm- and oocyte-derived chromosomes. Indeed, genetics analysis of wild-
type and Tet3 maternal knockout (KO) embryos indicates that Tet3 deficiency affect DNA 
demethylation of both paternal and maternal genomes in one-cell zygotes 47,48.
The low level of 5hmC in the genome suggests that base-resolution mapping methods such 
as oxBS-seq and TAB-seq, require ultra-deep sequencing coverage (>100x) to achieve high-
confidence identification of 5hmC sites of low abundance. To overcome this limitation, a 
recent study has developed a more sensitive approach using the PvuRst1l family of 5hmC-
dependent restriction endonucleases 49. PvuRts1l endonuclease recognizes 5hmC and 
creates a double-stranded break 11–12 bp downstream, leaving a 2-bp 3′ overhang. The 
resulting DNA fragments can then be converted into sequencing libraries and the location of 
5hmC is determined by mapping the cleavage sites. Combining chemical labeling-based 
5hmC enrichment method, hMe-Seal 50, with PvuRst1l digestion, the method (termed Pvu-
Seal-seq) allows cost-efficient gnome-wide 5hmC mapping at base-resolution. Using Pvu-
Seal-seq, the authors have identified 20.8 million reproducible 5hmC sites in mouse ESCs 
(present in two technical replicates) (Table 1), 10-time higher than the number of 5hmC sites 
identified by whole-genome TAB-seq analysis. Among 5hmC sites identified by Pvu-Seal-
seq, 24% of them were in non-CpG context (~50% in CpA). This observation is surprising 
as results from both oxRRBS and whole-genome TAB-seq suggest that nearly all 5hmC 
sites are detected in the CpG context (~99%) 38,41. Interestingly, while 64% of 5hmCpG 
sites are conserved between the two biological replicates, only 24% of 5hmC in non-CpG 
context (5hmCpH) are reproducibly detected by Pvu-Seal-seq. The results imply that 
5hmCpH is much less stable than 5hmCpG, possibly due to the fact that 5mC in non-CpG 
context cannot be faithfully maintained during cell division. Locus-specific TAB-seq 
analysis (sequencing depth >100x) confirmed some of the newly identified 5hmCpH sites, 
and revealed that the average 5hmC level at non-CpG context (2.8%) is significantly lower 
than that of 5hmCpG (11.4%), highlighting the need of ultra-high sequencing depth for 
detecting 5hmCpH with high confidence. Overall, these results suggest that Pvu-Seal-seq 
has enhanced sensitivity and can detect low abundance and/or unstable 5hmC sites in the 
genome without the need of ultra-high sequencing depth. However, due to the initial step of 
affinity-enrichment, Pvu-Seal-seq cannot quantify the absolute percentage of 5hmC level. 
Thus, it can only be used to quantify relative changes of 5hmC levels.
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Base-resolution mapping of 5fC and 5caC in mammalian genomes
Available evidence suggests that oxidative modification of 5mC by TET proteins promotes 
DNA demethylation by either replication-dependent dilution of 5hmC (by impeding 
DNMT1 function) or TDG-mediated 5fC/5caC excision followed by BER 13. The active 
DNA demethylation pathway involving generation and excision repair of 5fC/5caC is of 
particular interest as it may occur in both proliferating and post-mitotic cells. The 
observation that 5hmC in CpG context is relatively stable in vivo suggests that identifying 
methylated CpGs that are targeted for active DNA demethylation requires methods that 
permit quantitative measurement of 5fC and 5caC levels at single-base resolution. Despite 
the scarcity of 5fC and 5caC in the genome, several modified BS-seq methods have been 
developed for mapping 5fC and 5caC at single-base resolution (Fig. 2).
Subtraction-dependent methods—This group of base-resolution mapping methods 
utilizes specific chemical treatment to protect 5fC or 5caC from deamination by bisulfite 
treatment. To map 5fC, fCAB-seq (5fC chemically assisted bisulfite sequencing) utilizes O-
ethylhydroxylamine (EtONH2) to protect 5fC 32. In a similar approach called reduced 
bisulfite sequencing (redBS-seq), 5fC is selectively reduced by sodium borohydride 
(NaBH4) to 5hmC 51. To protect 5caC, caCAB-seq (5caC chemically assisted bisulfite 
sequencing) takes advantage of 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide 
hydrochloride (EDC)-based coupling to chemically block 5caC from deamination 52. 
However, all three methods require subtracting signals of standard BS-seq from those of 
modified BS-seq to determine the position and abundance of 5fC (fCAB-seq and redBS-seq) 
or 5caC (caCAB-seq). The low abundance of 5fC/5caC, coupled with the possibility that 
chemicals used in these methods may react with moieties (e.g. EtONH2 reacts with abasic 
sites or unmodified C) on DNA other than their intended targets (5fC or 5caC) may 
complicate the interpretation of the results. To reduce sequencing efforts, various 
enrichment strategies were integrated with subtraction-dependent 5fC/5caC base-resolution 
mapping methods to generate genome-scale maps. By combining chromatin 
immunoprecipitation (using antibody against mono-methylation of lysine 4 on histone H3 
[H3K4me1]) with fCAB-seq (termed H3K4me1-fCAB-seq), 5fC abundance can be 
examined within a fraction of genome that are associated with active/poised enhancer 
activity 32. Integrating redBS-seq and RRBS allows 5fC mapping within genomic regions 
containing CpG-rich sequences (mostly gene promoters) 51. It is important to point out that 
the MspI enzyme used in standard RRBS only partially digests 5fC containing C^CGG sites 
and completely fail to cut 5caCpGs 19. Thus, either reducing 5fC to 5hmC before MspI 
digestion or choosing an enzyme (e.g. TaqαI, T^CGA) less influenced by 5fC/5caC 
modifications should be considered when using the RRBS strategy for 5fC/5caC base-
resolution analysis. More recently, DNA immunoprecipitation (using antibody against 5fC 
or 5caC) is used to first enrich DNA fragments containing these rare modified bases before 
fCAB-seq and caCAB-seq assays. In this DIP-CAB-seq strategy, although the position of 
5fC and 5caC can be precisely mapped, only relative enrichment of 5fC or 5caC can be 
determined 53. Because of the need of ultra-high sequencing depth, subtraction-based 5fC/
5caC mapping methods are not well-suited for genome-scale quantitative analysis of 5fC 
and 5caC at base-resolution.
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Subtraction-independent methods—Because 5fC and 5caC are present at extremely 
low levels in the genome, it is highly desirable to map these rare bases without the need of 
subtracting two BS-seq experiments. In addition, as both 5fC and 5caC are substrate for 
TDG-mediated excision repair, determine the strand-specific preference of TET/TDG-
mediated demethylation activity requires the ability to simultaneously map both 5fC and 
5caC in a single experiment. To circumvent these limitations, three groups recently 
developed a modified BS-seq method, called methylase-assisted bisulfite sequencing (MAB-
seq), to directly map 5fC/5caC at single-base resolution 48,54,55. In MAB-seq, genomic 
DNA is first treated with the bacterial DNA CpG methyltransferase M.SssI, an enzyme that 
is known to efficiently methylate CpG dinucleotides. Bisulfite conversion of methylase-
treated DNA may lead to deamination of only 5fC and 5caC; originally unmodified CpGs 
are protected as 5mCpG. Subsequent sequencing would reveal 5fC and 5caC as T, whereas 
C/5mC/5hmC would be read out as C. Notably, MAB-seq is unable to distinguish 5fC/5caC 
from unmodified C within a non-CpG context due to the poor activity of M.SssI towards 
CpH. Building upon MAB-seq, we have further developed a method termed caMAB-seq 
(5caC methylase-assisted bisulfite sequencing) to directly map 5caC at single-base 
resolution. This modified version of MAB-seq takes advantage of the fact that 5fC can be 
selectively reduced by NaBH4 to 5hmC. After M.SssI-treated DNA was further incubated 
with NaBH4, only 5caC was read out as T; original 5fC, along with C/5mC/5hmC, is read as 
C in caMAB-seq. By integrating NaBH4-mediated 5fC reduction into the Pvu-Seal-seq 
workflow, a modified Pvu-Seal-seq method can also directly detect 5fC at base-resolution.
Genomic distribution of 5fC and 5caC in stem cells and early development—
The whole-genome base-resolution map of 5fC was first generated in two-cell embryos 
using fCAB-seq assays 46. By subtracting standard BS-seq signals from those of fCAB-seq, 
this analysis identified ~0.95 million 5fCpGs genome-wide with an averaged level of ~50% 
at individual CpGs. Given the moderate sequencing depth (18× per cytosines) and relatively 
conservative statistical filtering strategy (Fisher’s exact test), the number of 5fCpGs present 
in the genome of two-cell embryos is likely under-estimated. Sanger-sequencing-based 
locus-specific MAB-seq was also used to analyze early developing embryos, and this 
analysis did not detect substantial levels of 5fC/5caC at several CpG-rich gene promoters 48.
Whole-genome base-resolution map of 5fC/5caC has recently been generated using MAB-
seq for wild-type and Tdg-depleted mouse ESCs 54,55. Deep sequencing analysis (>50× per 
cytosine) of wild-type mouse ESCs has identified ~0.3 million 5fC/5caC-modified CpGs 
(5fC/5caCpGs) with an average modification level of 8–10% 55 (Table 1). Interestingly, 
5fC/5caCpGs are found to be enriched at active gene promoters and enhancers in wild-type 
ESCs, co-localizing with both TET1/2 and TDG proteins 55. Reduced representation version 
of MAB-seq (RRMAB-seq) allows more focused analysis of 5fC/5caC at CpG-rich 
promoters in wild-type and Tdg-depleted cells, revealing a Dnmt/TET/TDG-coupled DNA 
methylation/demethylaion dynamic process at actively transcribed gene promoters. Because 
both the increase of 5mC in Tet1/2-depleted cells (from ~2% to ~5%) and the increase of 
5fC/5caC level in Tdg-depleted cells are quite modest at these active promoters in mouse 
ESCs, TET/TDG-mediated active DNA demethylation pathway may only play a relatively 
minor role in protecting these CpG-rich promoters from being hypermethylated. Redundant 
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mechanisms such as H3K4 methylation-dependent repulsion of DNMTs 56 and KDM2B 
(also known as FBXL10 or CXXC2) mediated protection against DNA hypermethylation 57 
may compensate for the loss of function of TET enzymes.
Using Dnmt triple KO and Tet1/2 double KO mouse ESCs (5fC/5caC-free genome) as the 
reference for controlling false-discovery rate, whole-genome base-resolution 5fC/5caC 
mapping (14× per cytosine) in Tdg-depleted mouse ESCs identified ~0.7 million 5fC/
5caCpGs with an average of 20–30% modification level 54 (Table 1). 5fC/5caCpGs are most 
enriched at DNase I hypersensitivity sites, H3K4me1-marked ESC enhancers, CTCF-bound 
insulators and exonic regions. Strand-specific comparative analysis of 5fC/5caCpG and 
5hmCpG base-resolution mapping revealed that the majority of 5hmCpGs (>90%) do not 
overlap with 5fC/5caCpGs, suggesting proteins exhibit distinct catalytic processivity at 
different CpGs. Further analysis suggests that the processivity of TET-mediated iterative 
oxidation positively correlates with local chromatin accessibility, such that 5fC/5caCpGs 
(including both 5fC/5caC-alone and dual modified CpGs) are associated with higher levels 
of DNase I hypersensitive sites, histone variants (H2A.Z and H3.3) known to destabilize 
nucleosome structure, and pluripotency-related TFs (Oct4/Nanog/Sox2) than 5hmC-alone 
CpGs 54. Similar to strand asymmetry of 5hmCpGs 41, 5fC/5caCpGs also exhibit strong 
preference for asymmetrical modification 54,55, suggesting that single-strand breaks (SSBs) 
rather than double-strand breaks (DSBs) are the predominant intermediates during TET/
TDG-mediated active DNA demethylation process. While 5hmC in the non-CpG context is 
rare and/or unstable, the presence of low abundance 5fC/5caCpGs cannot be excluded. 
Indeed, base-resolution 5fC mapping by the sensitive Pvu-Seal-seq has identified 6.2 million 
5fC sites (75% in CpG and 25% in CpH) in wild-type mouse ESCs 49 (Table 1), 
significantly higher than the number of 5fC/5caC sites identified by MAB-seq. Future 
studies are needed to resolve this discrepancy between different methods.
Concluding remarks
The discovery of oxidized forms of methylcytosines, including 5hmC, 5fC and 5caC, in 
mammalian genomes has stimulated intense effort to map and quantify these modifications 
in different cell types, particularly in embryonic stem cells and developing brain tissues. The 
major challenge for such efforts is the scarcity of the 5mC oxidation products in mammalian 
cells. Application of BS-seq on chemically or enzymatically modified genomic DNA has 
generated single-base resolution maps of 5hmC, 5fC and 5caC. Comparative analysis of 
these maps with other epigenomic maps suggests that 5hmC/5fC/5caC are not randomly 
distributed in the mammalian genome, but rather preferentially enriched at specific genomic 
features with important gene regulatory functions.
In conclusion, recent technological advances in single-base resolution profiling of oxidized 
methylcytosine bases have provided significant new insights into the mechanism and 
function of TET- and TDG-mediated active DNA demethylation process. However, new 
experimental methods and strategies are needed to allow us to achieve integrated analysis of 
all five distinct cytosine modification states in small number of cells, particularly in 
preimplantation embryos and primordial germ cells where dynamic global DNA methylation 
changes are observed. Emerging technologies such as SMRT and nanopore sequencing have 
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the potential for direct reading of DNA modifications on single molecules without the need 
of DNA amplification or bisulfite conversion 36,37 (Table 1). However, the throughput and 
accuracy of these third-generation sequencing methods need to be substantially improved 
before they can be used for analyzing complex mammalian genomes.
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Figure 1. Schematic diagram of potential functions for 5hmC, 5fC and 5caC
(a) Oxidized methylcytosines (i.e. 5hmC/5fC/5caC) serve as intermediate products in TET/
TDG-mediated active DNA demethylation process.
(b) All oxidized cytosine bases may act as stable or transient epigenetic marks by attracting 
or repelling specific DNA binding proteins.
(c) 5fC and 5caC may have additional gene regulatory functions, including retarding RNA 
polymerase II elongation or altering DNA conformation.
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Figure 2. Schematic diagram of base-resolution mapping methods for 5hmC, 5fC and 5caC
DNMT methylates unmodified C to generate 5mC, which can be successively oxidized by 
TET to generate 5hmC/5fC/5caC. Highly oxidized cytosine variatnts, 5fC and 5caC, are 
repared by TDG/BER to regenerate unmodified C. In conjunction with various chemical (in 
red) and enzymatic (in black) treatment, bisulfite sequencing (BS-seq) or 5hmC-dependent 
endonuclease PvuRts1l-based method have been developed to map unmodified C (“MAB-
seq sub BS-seq”), 5mC (oxBS-seq, “BS-seq sub TAB-seq”), 5hmC (“BS-seq sub oxBS-
seq”, TAB-Seq and Pvu-Seal-seq), 5fC (“fCAB-Seq sub BS-seq”, “redBS-seq sub BS-seq”, 
“caMAB-seq sub MAB-seq” and modified Pvu-Seal-seq), 5caC (“caCAB-Seq sub BS-seq” 
and caMAB-seq), 5fC/5caC (MAB-seq). In contrast to direct mapping methods (e.g. oxBS-
seq for 5mC, TAB-seq for 5hmC and MAB-seq for 5fC/5caC), other BS-seq-based mapping 
strategies (e.g. oxBS-seq for 5hmC, fCAB-seq for 5fC and caCAB-seq for 5caC) require 
subtracting signals between conventional BS-Seq from those of modified BS-Seq to 
indirectly determine the position and abundance of oxidized 5mC bases. In Pvu-Seal-seq, 
genomic DNA is first digested with PvuRts1l. This endonuclease recognizes 5hmC and 
creates a double-stranded break 11–12 bp downstream, leaving a 2 bp 3′ overhang. While 
PvuRts1l exhibits highest activity on 5hmC, it also recognizes 5mC or C, albeti with a lower 
cleavage activity. To increase the specificity of 5hmC mapping, a chemical labeling step 
(tag 5hmC with biotin) is needed to selectively enrich 5hmC-containing DNA fragments 
after PvuRts1l digestion. Unlike BS-seq-based mapping methods, Pvu-Seal-seq involves a 
affinity enrichment step and cannot quantify the absolute levels of 5hmC or 5fC sites.
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